Patent · US Active

Cell line for screening influenza virus polymerase assembly inhibitor and construction method thereof

US10526634B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2016
Grant dateJan 7, 2020
Priority date
Expiry dateDec 28, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/11
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are a cell line PA/PB1 HEK293T (Teton) for screening an influenza virus polymerase assembly inhibitors and a construction method thereof. The PA/PB1 HEK293T (Teton) cell line is constructed by integrating a vector expressing PA-GlucC fusion protein and a vector expressing GlucN-PB1 fusion protein into a HEK293T (Teton) cell via a triple plasmid system of pMDLg/pRRE, pRSV-Rev and pMD2.G. The HEK293T (Teton) cell line is formed by transforming a TOP10 competent cell with a synthesized Teton-3G gene fragment ligated to a lentiviral vector FG.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.